RB1 genetic testing as a clinical service: A follow-up study

Medical and Pediatric Oncology

Volumn 37, Issue 4, 2001, Pages 372-378

  Cohen, Jennifer G ^a   Dryja, Thaddeus P ^b   Davis, Katherine B ^c   Diller, Lisa R ^a   Li, Frederick P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Genetic testing; Late effects; RB1; Retinoblastoma

Indexed keywords

ARTICLE; CANCER SCREENING; CONSULTATION; CONTROLLED STUDY; GENETIC SCREENING; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PATIENT COUNSELING; PRIORITY JOURNAL; RETINOBLASTOMA;

ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENES, RETINOBLASTOMA; GENETIC SCREENING; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; MALE; QUESTIONNAIRES; RETINAL NEOPLASMS; RETINOBLASTOMA; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0034797978     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1213     Document Type: Article

References (28)

1. Mutation and cancer: Statistical study of retinoblastoma
2. Retinoblastoma: A prototypic hereditary neoplasm
3. Predicting the risk of hereditary retinoblastoma
4. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
5. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
6. Identification of the breast cancer susceptibility gene BRCA2
7. Identification and characterization of the familial adenomatous polyposis coli gene
8. The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colorectal cancer
9. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer
10. Mutations of a routs homolog in hereditary nonpolyposis colorectal cancer
11. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
12. Identification and management of inherited cancer susceptibility
13. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk
14. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene
15. Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis
16. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing
17. Complete genomic sequence of the human retinoblastoma susceptibility gene
18. Parental origin of mutations of the retinoblastoma gene
19. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
20. Detection of DNA sequence polymorphisms of enzymatic amplification and direct genomic sequencing
21. Oncogenic point mutations in the human retinoblastoma gene: Their application of genetic counseling
22. Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk
23. Proceed with care: Direct predictive testing for Huntington disease
24. Human cancer syndromes: Clues to the origin and nature of cancer
25. Frequency of BRCA1/ BRCA2 mutations in a population-based sample of young breast carcinoma cases
26. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
27. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: A decision analysis
28. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations